Wednesday, February 10, 2010, 4:28am EST - Canadian Markets open in 5 hours and 2 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Haemonetics Corp. (HAE)

On Feb 9: 52.79 USD   0.00 (0.00%)  
MORE ON HAE
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 26-Dec-09 26-Sep-09 27-Jun-09 28-Mar-09
Total Revenue 165,168   157,071   154,087   152,397  
Cost of Revenue 79,721   76,104   71,144   70,249  
Gross Profit 85,447   80,967   82,943   82,148  
Operating Expenses
Research Development 6,462   6,475   6,777   6,958  
Selling General and Administrative 53,151   47,469   49,839   57,057  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 25,834   27,023   26,327   18,133  
Income from Continuing Operations
Total Other Income/Expenses Net (198) (704) (178) 296  
Earnings Before Interest And Taxes 25,636   26,319   26,149   18,429  
Interest Expense 259   249   214   64  
Income Before Tax 25,377   26,070   25,935   18,365  
Income Tax Expense 7,091   8,020   7,862   4,426  
Minority Interest -   -   -   -  
Net Income From Continuing Ops 18,286   18,050   18,073   13,939  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 18,286   18,050   18,073   13,939  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares $18,286   $18,050   $18,073   $13,939  

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol:
Symbol Lookup
Latest News Canadian Indices


Reuters offers more in-depth Company Research , Stock Screening , and Risk Alerts on over 10,000 U.S. Equities.